.

Deeper Knowledge, Faster

  • Find suppliers and generic API sources
  • Obtain formulation and manufacturing information
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Julphar
Teva
Deloitte
UBS
Novartis
McKesson
AstraZeneca
Fish and Richardson
Daiichi Sankyo
Merck

Generated: July 26, 2017

DrugPatentWatch Database Preview

NAPHAZOLINE HYDROCHLORIDE Drug Profile

« Back to Dashboard

Which patents cover Naphazoline Hydrochloride, and when can generic versions of Naphazoline Hydrochloride launch?

Naphazoline Hydrochloride is a drug marketed by Akorn Inc and Altaire Pharms Inc and is included in three NDAs.

The generic ingredient in NAPHAZOLINE HYDROCHLORIDE is naphazoline hydrochloride; pheniramine maleate. There are six drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the naphazoline hydrochloride; pheniramine maleate profile page.

Summary for Tradename: NAPHAZOLINE HYDROCHLORIDE

Patents:0
Applicants:2
NDAs:3
Suppliers / Packagers: see list4
Bulk Api Vendors: see list43
Clinical Trials: see list2,254
Patent Applications: see list842
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:NAPHAZOLINE HYDROCHLORIDE at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Akorn Inc
NAPHAZOLINE HYDROCHLORIDE
naphazoline hydrochloride
SOLUTION/DROPS;OPHTHALMIC083590-001Approved Prior to Jan 1, 1982RXNoYes► Subscribe► Subscribe► Subscribe
Altaire Pharms Inc
NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE
naphazoline hydrochloride; pheniramine maleate
SOLUTION/DROPS;OPHTHALMIC078208-001Sep 27, 2010OTCNoNo► Subscribe► Subscribe► Subscribe
Akorn Inc
NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE
naphazoline hydrochloride; pheniramine maleate
SOLUTION/DROPS;OPHTHALMIC202795-001Jan 24, 2013OTCNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

US Department of Justice
Julphar
US Army
McKinsey
Dow
Johnson and Johnson
Chinese Patent Office
Cerilliant
Medtronic
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot